rct
    2022
    High Quality

    A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost) on mood and cognition in healthy young adults

    Bell L, et al.

    Published in European Journal of Nutrition

    Methodology

    Randomised, double-blind, placebo-controlled trial assessing acute (single-dose) and chronic (two-week) effects of American ginseng extract on computerised cognitive tasks and mood scales in healthy young adults.

    Key Findings

    In 61 healthy young adults, American ginseng extract (Cereboost) improved working memory performance acutely, notably at 3 hours post-dose, and improved self-reported calmness, but two weeks of chronic dosing produced no additional cognitive benefit and mood effects were mixed.

    Conclusions

    American ginseng produced acute working-memory and calmness benefits in healthy young adults, without clear added benefit from two weeks of continued use.

    Limitations

    Small healthy young sample limiting generalisability to older or cognitively impaired people, short two-week chronic phase, multiple cognitive outcomes raising the chance of false positives, and manufacturer involvement in supplying the extract.

    Supplements Studied

    This study confirmed the promising effects of Cereboost on cognitive function and mood

    Related Health Concerns

    Study Details

    Year:2022
    Sample Size:61
    Duration:2 weeks
    Quality Score:7/10

    Disclosures

    Funding

    Industry-supported (Cereboost extract manufacturer) with academic conduct

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.